Literature DB >> 11190418

Late onset asthma: epidemiology, diagnosis and treatment.

B T Kitch1, B D Levy, C H Fanta.   

Abstract

Asthma is common among older persons, affecting approximately 4 to 8% of those above the age of 65 years. Despite its prevalence, late onset asthma may be misdiagnosed and inadequately treated, with important negative consequences for the patient's health. The histopathology of late onset disease appears to be similar to that of asthma in general, with persistent airway inflammation a characteristic feature. It is less clear, however, that allergic exposure and sensitisation play the same role in the development of disease in adults as they do in children. Atopy is less common among those with late onset asthma, and the prevalence of elevated immunoglobulin E levels is lower among those aged over 55 years of age than younger patients. Occupational asthma is an aetiological consideration unique to adult onset disease, with important implications for treatment. The differential diagnosis for cough, wheeze, and dyspnoea in the elderly is broad, and includes chronic obstructive bronchitis, bronchiectasis, congestive heart failure, lung cancer with endobronchial lesion and vocal cord dysfunction. Keys to accurate diagnosis include a good history and physical examination, the demonstration of reversible airways obstruction on pulmonary function tests and a favorable response to treatment. Inhaled corticosteroid therapy is recommended for patients with persistent disease, and careful instruction in the use of metered-dose inhalers is particularly important for the elderly.

Entities:  

Mesh:

Year:  2000        PMID: 11190418     DOI: 10.2165/00002512-200017050-00005

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  67 in total

Review 1.  Treatment of asthma with drugs modifying the leukotriene pathway.

Authors:  J M Drazen; E Israel; P M O'Byrne
Journal:  N Engl J Med       Date:  1999-01-21       Impact factor: 91.245

2.  Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial.

Authors:  J Vestbo; T Sørensen; P Lange; A Brix; P Torre; K Viskum
Journal:  Lancet       Date:  1999-05-29       Impact factor: 79.321

3.  Effect of montelukast on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers.

Authors:  A Van Hecken; M Depré; R Verbesselt; K Wynants; I De Lepeleire; J Arnout; P H Wong; A Freeman; S Holland; B Gertz; P J De Schepper
Journal:  J Clin Pharmacol       Date:  1999-05       Impact factor: 3.126

4.  A comparison of breath-actuated and conventional metered-dose inhaler inhalation techniques in elderly subjects.

Authors:  K R Chapman; L Love; H Brubaker
Journal:  Chest       Date:  1993-11       Impact factor: 9.410

5.  Association of ocular cataracts with inhaled and oral steroid therapy during long-term treatment of asthma.

Authors:  J H Toogood; A E Markov; J Baskerville; C Dyson
Journal:  J Allergy Clin Immunol       Date:  1993-02       Impact factor: 10.793

6.  Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma.

Authors:  M E Wechsler; D Finn; D Gunawardena; R Westlake; A Barker; S P Haranath; R A Pauwels; J C Kips; J M Drazen
Journal:  Chest       Date:  2000-03       Impact factor: 9.410

7.  The interaction between immunoglobulin E and smoking in airflow obstruction in the elderly.

Authors:  L Dow; D Coggon; M J Campbell; C Osmond; S T Holgate
Journal:  Am Rev Respir Dis       Date:  1992-08

8.  Comparisons of asthma, emphysema, and chronic bronchitis diagnoses in a general population sample.

Authors:  R Dodge; M G Cline; B Burrows
Journal:  Am Rev Respir Dis       Date:  1986-06

9.  Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids.

Authors:  N A Hanania; K R Chapman; W C Sturtridge; J P Szalai; S Kesten
Journal:  J Allergy Clin Immunol       Date:  1995-11       Impact factor: 10.793

10.  Influence of age on response to ipratropium and salbutamol in asthma.

Authors:  M I Ullah; G B Newman; K B Saunders
Journal:  Thorax       Date:  1981-07       Impact factor: 9.139

View more
  8 in total

1.  Interaction of occupational and personal risk factors in workforce health and safety.

Authors:  Paul A Schulte; Sudha Pandalai; Victoria Wulsin; HeeKyoung Chun
Journal:  Am J Public Health       Date:  2011-11-28       Impact factor: 9.308

2.  Major depressive disorder is associated with subsequent adult-onset asthma: a population-based cohort study.

Authors:  T-C Shen; C-L Lin; C H Liao; C-C Wei; F-C Sung; C-H Kao
Journal:  Epidemiol Psychiatr Sci       Date:  2016-09-19       Impact factor: 6.892

Review 3.  Biomarkers of progression of chronic obstructive pulmonary disease (COPD).

Authors:  Janet G Shaw; Annalicia Vaughan; Annette G Dent; Phoebe E O'Hare; Felicia Goh; Rayleen V Bowman; Kwun M Fong; Ian A Yang
Journal:  J Thorac Dis       Date:  2014-11       Impact factor: 2.895

Review 4.  Complexities of diagnosis and treatment of allergic respiratory disease in the elderly.

Authors:  Paula J Busse; Kiran Kilaru
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

Review 5.  Optimal management of asthma in elderly patients: strategies to improve adherence to recommended interventions.

Authors:  Dianne P Goeman; Jo A Douglass
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

6.  Asthma in the elderly.

Authors:  Domenico Lorenzo Urso
Journal:  Curr Gerontol Geriatr Res       Date:  2009-10-27

7.  Old dilemma: asthma with irreversible airway obstruction or COPD.

Authors:  Fatemeh Fattahi; Judith M Vonk; Nicole Bulkmans; Ruth Fleischeuer; Annette Gouw; Katrien Grünberg; Thais Mauad; Helmut Popper; Aloisio Felipe-Silva; Bart Vrugt; Joanne L Wright; Hui-Min Yang; Janwillem W H Kocks; Machteld N Hylkema; Dirkje S Postma; Wim Timens; Nick H T Ten Hacken
Journal:  Virchows Arch       Date:  2015-09-14       Impact factor: 4.064

8.  The Advance of Personalized and Stratified Therapies in Bronchial Asthma: Phenotypes - Endotypes - Biomarkers.

Authors:  Sebastian Lauer; Harald Renz
Journal:  EJIFCC       Date:  2013-02-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.